Literature DB >> 2474201

Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease.

B A Yankner1, L R Dawes, S Fisher, L Villa-Komaroff, M L Oster-Granite, R L Neve.   

Abstract

Amyloid deposition in senile plaques and the cerebral vasculature is a marker of Alzheimer's disease. Whether amyloid itself contributes to the neurodegenerative process or is simply a by-product of that process is unknown. Pheochromocytoma (PC12) and fibroblast (NIH 3T3) cell lines were transfected with portions of the gene for the human amyloid precursor protein. Stable PC12 cell transfectants expressing a specific amyloid-containing fragment of the precursor protein gradually degenerated when induced to differentiate into neuronal cells with nerve growth factor. Conditioned medium from these cells was toxic to neurons in primary hippocampal cultures, and the toxic agent could be removed by immunoabsorption with an antibody directed against the amyloid polypeptide. Thus, a peptide derived from the amyloid precursor may be neurotoxic.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2474201     DOI: 10.1126/science.2474201

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  190 in total

Review 1.  Genetic risk factors in Alzheimer's disease.

Authors:  L Tilley; K Morgan; N Kalsheker
Journal:  Mol Pathol       Date:  1998-12

2.  Inhibition of fibril formation in beta-amyloid peptide by a novel series of benzofurans.

Authors:  D R Howlett; A E Perry; F Godfrey; J E Swatton; K H Jennings; C Spitzfaden; H Wadsworth; S J Wood; R E Markwell
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

3.  Transgene delivery with a cationic lipid in the presence of amyloid beta (betaAP) peptide.

Authors:  P S Ajmani; W Wang; F Tang; M A King; E M Meyer; J A Hughes
Journal:  Neurochem Res       Date:  2001-03       Impact factor: 3.996

4.  Accumulation of amyloid precursor protein in neurons after intraventricular injection of colchicine.

Authors:  K Shigematsu; P L McGeer
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

Review 5.  Caspase-mediated degeneration in Alzheimer's disease.

Authors:  David H Cribbs; Wayne W Poon; Robert A Rissman; Mathew Blurton-Jones
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

6.  Sphingosine kinase-1 protects differentiated N2a cells against beta-amyloid25-35-induced neurotoxicity via the mitochondrial pathway.

Authors:  Yang Yang; Min Wang; Bingjie Lv; Rong Ma; Jing Hu; Yaoyan Dun; Shenggang Sun; Gang Li
Journal:  Neurochem Res       Date:  2014-03-30       Impact factor: 3.996

Review 7.  The Proteasome and Oxidative Stress in Alzheimer's Disease.

Authors:  Vicent Bonet-Costa; Laura Corrales-Diaz Pomatto; Kelvin J A Davies
Journal:  Antioxid Redox Signal       Date:  2016-08-25       Impact factor: 8.401

Review 8.  Immunization treatment approaches in Alzheimer's and prion diseases.

Authors:  Thomas Wisniewski; Einar M Sigurdsson
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

9.  Expression Profiles of SIRT1 and APP Genes in Human Neuroblastoma SK-N-SH Cells Treated with Two Epigenetic Agents.

Authors:  Yaping Hou; Fanghua Wang; Linping Cheng; Tao Luo; Jie Xu; Huaqiao Wang
Journal:  Neurosci Bull       Date:  2016-08-13       Impact factor: 5.203

Review 10.  A potential role for apoptosis in neurodegeneration and Alzheimer's disease.

Authors:  C W Cotman; A J Anderson
Journal:  Mol Neurobiol       Date:  1995-02       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.